HighMark Wealth Management’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283 | Hold |
41
| – | – | ﹤0.01% | 577 |
|
|
2025
Q1 | $218 | Hold |
41
| – | – | ﹤0.01% | 548 |
|
|
2024
Q4 | $484 | Hold |
41
| – | – | ﹤0.01% | 532 |
|
|
2024
Q3 | $846 | Hold |
41
| – | – | ﹤0.01% | 523 |
|
|
2024
Q2 | $1.86K | Hold |
41
| – | – | ﹤0.01% | 476 |
|
|
2024
Q1 | $1.61K | Hold |
41
| – | – | ﹤0.01% | 487 |
|
|
2023
Q4 | $248 | Hold |
41
| – | – | ﹤0.01% | 551 |
|
|
2023
Q3 | $276 | Hold |
41
| – | – | ﹤0.01% | 540 |
|
|
2023
Q2 | $321 | Hold |
41
| – | – | ﹤0.01% | 532 |
|
|
2023
Q1 | $298 | Sell |
41
-108
| -72% | -$785 | ﹤0.01% | 573 |
|
|
2022
Q4 | $495 | Hold |
149
| – | – | ﹤0.01% | 501 |
|
|
2022
Q3 | $1K | Hold |
149
| – | – | ﹤0.01% | 467 |
|
|
2022
Q2 | $1K | Hold |
149
| – | – | ﹤0.01% | 468 |
|
|
2022
Q1 | $2K | Hold |
149
| – | – | ﹤0.01% | 437 |
|
|
2021
Q4 | $3K | Hold |
149
| – | – | ﹤0.01% | 397 |
|
|
2021
Q3 | $5K | Hold |
149
| – | – | ﹤0.01% | 353 |
|
|
2021
Q2 | $8K | Hold |
149
| – | – | 0.01% | 284 |
|
|
2021
Q1 | $9K | Sell |
149
-184
| -55% | -$11.1K | 0.01% | 242 |
|
|
2020
Q4 | $12K | Hold |
333
| – | – | 0.01% | 200 |
|
|
2020
Q3 | $18K | Hold |
333
| – | – | 0.02% | 174 |
|
|
2020
Q2 | $84K | Hold |
333
| – | – | 0.09% | 59 |
|
|
2020
Q1 | $52K | Buy |
+333
| New | +$52K | 0.06% | 64 |
|